ASEAN Blood Pressure Monitoring Devices Market Overview:
The ASEAN blood pressure monitoring devices market was valued at $31.5 million in 2017 and is expected to reach $53.3 million by 2025, registering a CAGR of 6.8% from 2018 to 2025. In terms of volume, the ambulatory BP monitors segment is expected to register the highest CAGR of 7.9% from 2018 to 2025.
Blood pressure is considered as one of the main risk factors for chronic heart diseases. Blood pressure monitoring devices are used to track a patients blood pressure prior to or during patient care. Technological advancements in the field of medical devices and ban on use of mercury-based BP monitors in the developed economies have fueled the development of digital BP monitors and ambulatory BP monitors. Advanced BP monitors allow the patient to easily monitor the blood pressure at home, or at the site of medical emergency.
Factors such as increase in geriatric population, rise in inclination toward home monitoring, and surge in prevalence of chronic diseases, such as cardiovascular disorders and obesity, drive the market in ASEAN countries. In addition, rise in the aging population, sedentary lifestyles, and emergence of advanced technologies also contribute to the growth of the market. However, lack of awareness regarding hypertension among patients in ASEAN countries is expected to hamper the market growth.
The ASEAN blood pressure monitoring devices market is segmented based on product and country. Based on product, the market is divided into aneroid BP monitors, digital BP monitors and ambulatory BP monitors. The ambulatory BP monitors segment is expected to register the highest CAGR of 6.9% (in terms of volume) from 2018 to 2025. By region, it is analyzed across Malaysia, Thailand, Vietnam, Philippines, Indonesia, and rest of ASEAN countries.
Key Benefits for ASEAN Blood Pressure Monitoring Devices Market:
The study provides an in-depth analysis of the ASEAN blood pressure monitoring devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the trends in the ASEAN blood pressure monitoring devices market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
ASEAN Blood Pressure Monitoring Devices Key Market Segments:
By Product
Aneroid Monitors
Digital BP Monitors
Ambulatory BP Monitoring Devices
By Country
Malaysia
Kuala Lumpur
George Town of Penang
Ipoh
Rest of Malaysia
Indonesia
Jakarta
Surabaya
Bandung
Rest of Indonesia
Thailand
Bangkok
Nonthaburi
Nakhon Ratchasima
Rest of Thailand
Philippines
Quezon City
Manila
Caloocan
Rest of Philippines
Vietnam
Da Nang
Hanoi
Ho Chi Minh City
Rest of Vietnam
Rest of ASEAN Countries
Singapore
Laos
Cambodia
Myanmar
Brunei
Key Market Players
A&D company, limited
Contec medical systems Co. ltd.
GE healthcare
Hill rom holdings, Inc
Koninklijke Philips N.V.
Masimo corporation
Nihon Kohden corporation
Omron Corporation
Smiths Group Plc
Halma PLC
The other players in the value chain include:
SunTech Medical
Rossmax International Ltd
Spacelabs Healthcare Inc.
Panasonic Corporation
Microlife AG
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top Winning Strategies
3.3. Porters five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in geriatric population
3.4.1.2. Surge in prevalence of hypertension
3.4.1.3. Rise in demand for portable monitoring devices
3.4.2. Restraint
3.4.2.1. Lack of awareness in developing countries
3.4.3. Opportunities
3.4.3.1. Increase in healthcare expenditure in emerging economies
3.4.3.2. Proactive monitoring
CHAPTER 4: BLOOD PRESSURE MONITORING DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Aneroid BP monitors
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.3. Digital blood pressure monitors
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.4. Ambulatory BP monitors
4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
CHAPTER 5: BLOOD PRESSURE MONITORING DEVICES MARKET, BY COUNTRY
5.1. Overview
5.1.1. Distribution Cost Analysis
5.1.2. Market size and forecast
5.2. Malaysia
5.2.1. Key trends and opportunities
5.2.2. Top Player
5.2.3. Competitive Landscape
5.2.4. Distribution Channels
5.2.5. Malaysia market size and forecast, by product
5.2.6. Malaysia market size and forecast, by city
5.2.6.1. Kuala Lumpur
5.2.6.1.1. Kuala Lumpur market size and forecast
5.2.6.2. George Town of Penang
5.2.6.2.1. George Town of Penang market size and forecast
5.2.6.3. Ipoh
5.2.6.3.1. Ipoh market size and forecast
5.2.6.4. Rest of Malaysia
5.2.6.4.1. Rest of Malaysia market size and forecast
5.3. Indonesia
5.3.1. Key trends and opportunities
5.3.2. Top Player
5.3.3. Competitive landscape
5.3.4. Distribution channels
5.3.5. Indonesia market size and forecast, by product
5.3.6. Indonesia market size and forecast, by city
5.3.6.1. Jakarta
5.3.6.1.1. Jakarta market size and forecast
5.3.6.2. Surabaya
5.3.6.2.1. Surabaya market size and forecast
5.3.6.3. Bandung
5.3.6.3.1. Bandung market size and forecast
5.3.6.4. Rest of Indonesia
5.3.6.4.1. Rest of Indonesia market size and forecast
5.4. THAILAND
5.4.1. Key trends and opportunities
5.4.2. Top Player
5.4.3. Competitive landscape
5.4.4. Distribution channels
5.4.5. Thailand market size and forecast by product
5.4.6. Thailand market size and forecast by city
5.4.6.1. Bangkok
5.4.6.1.1. Bangkok market size and forecast
5.4.6.2. Nonthaburi
5.4.6.2.1. Nonthaburi market size and forecast
5.4.6.3. Nakhon Ratchasima
5.4.6.3.1. Nakhon Ratchasima market size and forecast
5.4.6.4. Rest of Thailand
5.4.6.4.1. Rest of Thailand market size and forecast
5.5. PHILIPPINES
5.5.1. Key market trends and opportunities
5.5.2. Top Player
5.5.3. Competitive landscape
5.5.4. Distribution channels
5.5.5. Philippines market size and forecast, by product
5.5.6. Philippines market size and forecast, by city
5.5.6.1. Quezon City
5.5.6.1.1. Quezon City market size and forecast
5.5.6.2. Manila
5.5.6.2.1. Manila market size and forecast
5.5.6.3. Caloocan market size and forecast
5.5.6.3.1. Caloocan market size and forecast
5.5.6.4. Rest of Philippines
5.5.6.4.1. Rest of Philippines market size and forecast
5.6. Vietnam
5.6.1. Key market trends and opportunities
5.6.2. Top Player
5.6.3. Competitive landscape
5.6.4. Distribution channels
5.6.5. Vietnam market size and forecast, by product
5.6.6. Vietnam market size and forecast, by city
5.6.6.1. Da Nang
5.6.6.1.1. Da Nang market size and forecast
5.6.6.2. Hanoi
5.6.6.2.1. Hanoi market size and forecast
5.6.6.3. Ho Chi Minh City
5.6.6.3.1. Ho Chi Minh City market size and forecast
5.6.6.4. Rest of Vietnam
5.6.6.4.1. Rest of Vietnam market size and forecast
5.7. Rest of ASEAN Countries
5.7.1. Rest of ASEAN countries market size and forecast, by product
5.7.1.1. Rest of ASEAN countries market size and forecast, by city
5.7.2. Singapore
5.7.2.1. Singapore market size and forecast
5.7.3. Laos
5.7.3.1. Laos market size and forecast
5.7.4. Cambodia
5.7.4.1. Cambodia market size and forecast
5.7.5. Myanmar
5.7.5.1. Myanmar market size and forecast
5.7.6. Brunei
5.7.6.1. Brunei market size and forecast
CHAPTER 6: COMPANY PROFILES
6.1. A&D COMPANY, LIMITED
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments
6.2. CONTEC MEDICAL SYSTEMS CO. LTD
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.3. GE HEALTHCARE
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Business performance
6.4. HILL ROM HOLDINGS, INC.
6.4.1. Company overview
6.4.2. Hill Rom: Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance
6.4.6. Key strategic moves and developments
6.5. KONINKLIJKE PHILIPS N.V.
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.5.6. Key Strategic Moves:
6.6. MASIMO CORPORATION
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.6.5. Business performance
6.6.6. Key Strategic Moves:
6.7. NIHON KOHDEN CORPORATION
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance
6.7.6. Key strategic moves and developments
6.8. OMRON CORPORATION
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance
6.8.6. Key strategic moves and developments
6.9. SMITHS GROUP PLC.
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance
6.9.6. Key strategic moves and developments
6.10. HALMA PLC.
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance
6.10.6. Key strategic moves and developments